These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7656232)

  • 1. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma.
    Kabir S; Daar GA
    Cancer Lett; 1995 Aug; 95(1-2):207-12. PubMed ID: 7656232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin 1beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer.
    Macrì A; Versaci A; Loddo S; Scuderi G; Travagliante M; Trimarchi G; Teti D; Famulari C
    Biomarkers; 2006; 11(2):184-93. PubMed ID: 16766394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of TNF-alpha as a surrogate marker for malnutrition and worse quality of life in patients with gastric cancer.
    Correia M; Cravo M; Marques-Vidal P; Grimble R; Dias-Pereira A; Faias S; Nobre-Leitão C
    Clin Nutr; 2007 Dec; 26(6):728-35. PubMed ID: 17949861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis.
    Torre D; Zeroli C; Giola M; Ferrario G; Fiori GP; Bonetta G; Tambini R
    Clin Infect Dis; 1994 Feb; 18(2):194-8. PubMed ID: 8161626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative and postoperative cytokines in patients with cancer.
    Nakazaki H
    Cancer; 1992 Aug; 70(3):709-13. PubMed ID: 1320454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma.
    Dosquet C; Schaetz A; Faucher C; Lepage E; Wautier JL; Richard F; Cabane J
    Eur J Cancer; 1994; 30A(2):162-7. PubMed ID: 8155390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of tumor necrosis factor-alpha, interleukin-1, and interleukin-6 in hemorrhagic fever with renal syndrome.
    Krakauer T; Leduc JW; Krakauer H
    Viral Immunol; 1995; 8(2):75-9. PubMed ID: 8825292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels and gene expressions of interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in human renal cell carcinomas].
    Hamao T; Kanayama H; Kan M; Takigawa H; Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1994 Apr; 85(4):563-70. PubMed ID: 8189655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration.
    Buemi M; Floccari F; Crisafulli A; Cavallaro E; Ruello A; Caccamo C; Loddo S; Aloisi C; Corica F; Romeo A; Frisina N; Teti D
    J Nephrol; 2005; 18(2):148-53. PubMed ID: 15931642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.
    Erturk K; Tastekin D; Serilmez M; Bilgin E; Bozbey HU; Vatansever S
    Tumour Biol; 2016 Jan; 37(1):405-12. PubMed ID: 26219901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.
    Danis VA; Franic GM; Rathjen DA; Laurent RM; Brooks PM
    Ann Rheum Dis; 1992 Aug; 51(8):946-50. PubMed ID: 1358037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    Sánchez-Zauco N; Torres J; Gómez A; Camorlinga-Ponce M; Muñoz-Pérez L; Herrera-Goepfert R; Medrano-Guzmán R; Giono-Cerezo S; Maldonado-Bernal C
    BMC Cancer; 2017 May; 17(1):384. PubMed ID: 28558708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.
    Grey A; Mitnick MA; Shapses S; Ellison A; Gundberg C; Insogna K
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3450-4. PubMed ID: 8855783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum levels of proinflammatory cytokines in women with uterine myomas].
    Sikorski R; Kapeć E; Zaleska W
    Ginekol Pol; 2001 Dec; 72(12A):1485-8. PubMed ID: 11883301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous serum deprivation restored IL-1 receptor antagonist production by peripheral blood mononuclear cells in patients with gastric cancer.
    Shimamura H; Iwagaki H; Gouchi A; Morimoto Y; Ariki N; Funaki M; Tanaka N
    J Int Med Res; 2000; 28(6):277-87. PubMed ID: 11191721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.
    Casey LC; Balk RA; Bone RC
    Ann Intern Med; 1993 Oct; 119(8):771-8. PubMed ID: 8379598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 plasma levels in neonatal sepsis.
    de Bont ES; Martens A; van Raan J; Samson G; Fetter WP; Okken A; de Leij LH
    Pediatr Res; 1993 Apr; 33(4 Pt 1):380-3. PubMed ID: 8479819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury?
    Kelly JL; O'Sullivan C; O'Riordain M; O'Riordain D; Lyons A; Doherty J; Mannick JA; Rodrick ML
    Ann Surg; 1997 May; 225(5):530-41; discussion 541-3. PubMed ID: 9193181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.